Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-25-010280
Filing Date
2025-07-10
Accepted
2025-07-10 18:45:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9688
  Complete submission text file 0001214659-25-010280.txt   11516
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-86428 | Film No.: 251117253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8581 SANTA MONICA BLVD LOS ANGELES CA 90069
Business Address
William Anderson Wittekind (Filed by) CIK: 0001753085 (see all company filings)

Type: SCHEDULE 13D/A